2,484
Views
2
CrossRef citations to date
0
Altmetric
Dermatology

Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients

, , , , &
Pages 1401-1410 | Received 16 Dec 2021, Accepted 15 Jun 2022, Published online: 05 Jul 2022

References

  • Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a Trinity. J Dermatol Sci. 2013;70(1):3–11.
  • Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1.
  • Furue M, Chiba T, Takeuchi S. Current status of atopic dermatitis in Japan. Asia Pac Allergy. 2011;1(2):64–72.
  • Sidbury R, Tom WL, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218–1233.
  • Silverberg JI, Gelfand JM, Margolis DJ, et al. Pain is a common and burdensome symptom of atopic dermatitis in United States adults. J Allergy Clin Immunol Pract. 2019;7(8):2699–2706.e7.
  • Vakharia PP, Chopra R, Sacotte R, et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119(6):548–552 e3.
  • Silverberg JI, Garg NK, Paller AS, et al. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol. 2015;135(1):56–66.
  • Maarouf M, Kromenacker B, Capozza KL, et al. Pain and itch are dual burdens in atopic dermatitis. Dermatitis. 2018;29(5):278–281.
  • von Kobyletzki LB, Thomas KS, Schmitt J, et al. What factors are important to patients when assessing treatment response: an international cross-sectional survey. Acta Derm Venereol. 2017;97(1):86–90.
  • Murota H, Inoue S, Yoshida K, et al. Cost of illness study for adult atopic dermatitis in Japan: a cross-sectional web-based survey. J Dermatol. 2020;47(7):689–698.
  • Egeberg A, Griffiths CEM, Williams HC, et al. Clinical characteristics, symptoms and burden of psoriasis and atopic dermatitis in adults. Br J Dermatol. 2020;183(1):128–138.
  • Yano C, Saeki H, Ishiji T, et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol. 2013;40(9):736–739.
  • Igarashi A, Fujita H, Arima K, et al. Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: a retrospective claims database analysis. J Dermatol. 2019;46(8):652–661.
  • Katoh N, Ohya Y, Ikeda M, et al. Japanese guidelines for atopic dermatitis 2020. Allergol Int. 2020;69(3):356–369.
  • Arima K, Gupta S, Gadkari A, et al. Burden of atopic dermatitis in Japanese adults: analysis of data from the 2013 national health and wellness survey. J Dermatol. 2018;45(4):390–396.
  • Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: disease-Specific programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063–3072.
  • Babineaux SM, Curtis B, Holbrook T, et al. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open. 2016;6(8):e010352.
  • Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371–380.
  • Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001;10(1):11–18.
  • Finlay AY, Khan GK. Dermatology life quality index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
  • Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol. 2004;140(12):1513–1519.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
  • EphMRA. European Pharmaceutical Market Research Association Code of Conduct/AER guidelines. 2019. [cited 2020 May 20]. Available from: https://www.ephmra.org/standards/code-of-conduct-aer/.
  • US Department of Health and Human Services. Summary of the HIPAA privacy rule. 2003. [cited 2020 May 29]. Available from: http://www.hhs.gov/sites/default/files/privacysummary.pdf.
  • Bliwise D, Anderson P, Wood R, et al. Negative impact of reduced first undisturbed sleep period on utility, productivity and health-related quality of life: results of a real world survey of patients in Europe and USA. Eur Urol Suppl. 2014;13(1):e591–e591a.
  • Ding B, Small M, Holmgren U. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications. Int J Chron Obstruct Pulmon Dis. 2017;12:1527–1537.
  • Tang DH, Colayco DC, Khalaf KM, et al. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int. 2014;113(3):484–491.
  • Dean BB, Crawley JA, Schmitt CM, et al. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003;17(10):1309–1317.
  • Rosekind MR, Gregory KB, Mallis MM, et al. The cost of poor sleep: workplace productivity loss and associated costs. J Occup Environ Med. 2010;52(1):91–98.
  • Huet F, Shourick J, Seite S, et al. Pain in atopic dermatitis: an online population-based survey. Acta Derm Venereol. 2020;100(14):adv00198.
  • Huet F, Taieb C, Corgibet F, et al. Pruritus, pain, and depression associated with the most common skin diseases: data from the French study “objectifs peau.” Dermatology. 2022;238(3):448–453.
  • Stander S, Simpson EL, Guttman-Yassky E, et al. Clinical relevance of skin pain in atopic dermatitis. J Drugs Dermatol. 2020;19(10):921–926.
  • Čelakovská J, Bukač J, Vaňková R, et al. The relation between the sensitization to molecular components of inhalant allergens and food reactions in patients suffering from atopic dermatitis. Food Agric Immunol. 2021;32(1):33–53.
  • Čelakovská J, Bukač J, Cermákova E, et al. Analysis of results of specific IgE in 100 atopic dermatitis patients with the use of multiplex examination ALEX2-Allergy explorer. IJMS. 2021;22(10):5286.
  • Misery L, Belloni Fortina A, El Hachem M, et al. A position paper on the management of itch and pain in atopic dermatitis from the international society of atopic dermatitis (ISAD)/oriented patient-education network in dermatology (OPENED) task force. J Eur Acad Dermatol Venereol. 2021;35(4):787–796.
  • Tanei R. Atopic dermatitis in older adults: a review of treatment options. Drugs Aging. 2020;37(3):149–160.
  • Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48(11):1507–1515.
  • Hartog ID, Willems DL, van den Hout WB, et al. Influence of response shift and disposition on patient-reported outcomes may lead to suboptimal medical decisions: a medical ethics perspective. BMC Med Ethics. 2019;20(1):61.